Professor Dame Jenny Harries
UK Health Security Agency · GBR
Track record: No forecast checked yet (1 not due, 1 being checked).
2forecasts & commitments on the record
50%can be checked as stated
54average ambiguity (0-100)
0goalpost moves recorded
0confirmed U-turns
Timeline
came true partly did not not due / being checked / too vague
Calibration score: shown after 10 checked forecasts with a stated likelihood (now 0).
How they speak about the future: stated on authority 1, based on data 1.
Kinds of claim: mixed claim 2.
In the nine words
How to read this
Each box is one sentence a public figure or institution said about the future, word for word, with a link to the official text. Can be checked means it names what will happen, by when, and how likely - so it can be compared with official figures later. Too vague to check means it does not. Ambiguity (0-100) is how many different ways the sentence can be read. When the date passes, the forecast is compared with official data and marked came true, partly or did not come true. Labels judge the sentence, never the person. Full guide and glossary.On the record (2)
We know that globally in 2019, 1.27 million deaths were directly attributable to AMR, and Lord Jim O’Neill’s independent review of antimicrobial resistance in collaboration with the Wellcome Trust, published in 2016, found that if insufficient action is taken, the number of deaths across the world could rise to 10 million a year by 2050, and the cost to the …
It is within the context of climate change we will have to tackle the challenge of AMR which we will be highlighting in a new UKHSA report on the health effects of climate change due for publication later this year.
Also said - not checkable as stated (4 newest)
Remarks about the future with no date, figure or likelihood that could be checked. They are kept on the record and shown here, but not scored.
Something which is a national threat to each one of us and our families, but importantly is also a problem which has different characteristics, which only joint working can solve, which everyone in this room can contribute to mitigating and where a loss of focus will mean huge loss of life – and that is the problem of antimicrobial resistance.
Without effective modern antibiotics, other antimicrobial treatments, vaccines and diagnostics, patients in the near future facing cancer treatment, colorectal surgery, hip replacements, caesarean sections or those harmed in war zones will be more likely to die from infections.
Perversely just when we start to develop personalised vaccines for otherwise complex cancer therapy, we may also find that what seemed simple lifesaving interventions in the form of antimicrobials in the past are no longer effective and it is infection that once again becomes the big killer.
Many people in this conference will be acutely aware that infectious disease persistently follows the very young and the very old, those already in ill health and those living in socio-economic deprivation.